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PURPOSE. We determine if several hours of controlled elevation of IOP (CEI) will produce the
optic nerve head (ONH) gene expression changes and optic nerve (ON) damage pattern
associated with early experimental glaucoma in rats.
METHODS. The anterior chambers of anesthetized rats were cannulated and connected to a
reservoir to elevate IOP. Physiologic parameters were monitored. Following CEI at various
recovery times, ON cross-sections were graded for axonal injury. Anterior ONHs were
collected at 0 hours to 10 days following CEI and RNA extracted for quantitative PCR
measurement of selected messages. The functional impact of CEI was assessed by
electroretinography (ERG).
RESULTS. During CEI, mean arterial pressure (99 6 6 mm Hg) and other physiologic
parameters remained stable. An 8-hour CEI at 60 mm Hg produced significant focal axonal
degeneration 10 days after exposure, with superior lesions in 83% of ON. Message analysis in
CEI ONH demonstrated expression responses previously identified in minimally injured ONH
following chronic IOP elevation, as well as their sequential patterns. Anesthesia with
cannulation at 20 mm Hg did not alter these message levels. Electroretinographic A- and B-
waves, following a significant reduction at 2 days after CEI, were fully recovered at 2 weeks,
while peak scotopic threshold response (pSTR) remained mildly but significantly depressed.
CONCLUSIONS. A single CEI reproduces ONH message changes and patterns of ON injury
previously observed with chronic IOP elevation. Controlled elevation of IOP can allow
detailed determination of ONH cellular and functional responses to an injurious IOP insult
and provide a platform for developing future therapeutic interventions.
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Understanding the cellular mechanisms that underlie glau-comatous optic nerve damage is essential for developing
new glaucoma therapies that can be used to augment
established pressure-lowering treatments. This involves identi-
fying the cellular events by which elevated IOP, a major risk
factor for glaucoma, produces axonal injury and retinal
ganglion cell (RGC) death. Because of the complexity of the
optic nerve head (ONH), the likely site of axonal injury,1–4
animal models should maintain the integrity of the ONH,
including its blood supply and close interrelationship between
axons, their supportive astrocytes, and surrounding connective
tissues. Developing such models to mimic the characteristics of
open angle glaucoma, with an emphasis on establishing a
chronic, sustained elevation of IOP, has long been a major
goal.5–9
Obstructing aqueous humor outflow in nonhuman primates
using laser-induced scarring of the trabecular meshwork
provides the most relevant paradigm to human glaucoma.10
Such models have provided important information on IOP-
induced physical forces within the ONH and how the presence
of its abundant connective tissues, particularly the lamina
cribrosa, may mediate and react to these forces. However, this
work must necessarily be limited to small numbers of animals,
making it less suitable for molecular biology studies. For this
reason, experimental and genetically-induced outflow obstruc-
tion models in rodents have gained increasing popularity as
glaucoma models.5,9,11–17
Over the past 20 years, work with several such models has
yielded important information on the site of injury,3,18 the
mechanism of cellular death of RGCs,19,20 and gene expression
changes that accompany optic nerve damage from elevated IOP
in the retina and optic nerve head.21–25 However, interpreting
these changes is challenging. If they are initial responses to the
pressure stimulus, these could be either injurious (causing
primary axonal injury) or protective. Alternatively, these
responses could be late and secondary to axonal loss.
Making these determinations requires an understanding of
the extent and duration of IOP elevation, which is a significant
challenge with all chronic glaucoma models. Obstruction of
aqueous humor outflow often results in marked fluctuations in
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IOP,26–29 which can be missed by intermittent tonometry. At
present, continuous telemetric pressure monitoring still is in
its infancy,30,31 although initial experience shows that fluctu-
ations in IOP are likely to be and can be unexpectedly large.32
We have found, while studying chronic glaucoma in Brown
Norway rats, that seemingly small IOP elevations can create
focal optic nerve injury.24,26,33 In addition, other investigators
have shown that a few hours of IOP elevation are sufficient to
produce reversible alterations in electroretinography
(ERG)11,34,35 and astrocyte morphology.36 These observations
suggest that the rodent ONH is relatively sensitive to IOP and
that a short period of IOP elevation, in which IOP is controlled,
may offer an opportunity to circumvent the limitations of
chronic glaucoma models.
We demonstrated that several hours of exposure to a known
level of elevated IOP (controlled elevation of IOP [CEI]) in
Brown Norway rats can produce axonal injury and ONH gene
expression changes that are similar to those described
previously in an established, chronic IOP elevation model.
We described this method and its effects on animal physiology,
the anatomic and functional evidence of optic nerve injury, and
initial observations of the resulting ONH gene expression
changes.
MATERIALS AND METHODS
Animals
Male Brown Norway rats, aged 6 to 8 months old (n ¼ 122)
were used in these experiments. Males were chosen to allow
comparison of gene expression responses from this new model
to our published results with chronic IOP elevation, which
were based on male animals, whose docile nature allows
reliable measurement of awake IOP.12 All protocols conformed
to the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research, and were approved by the Oregon Health and
Science University Institutional Animal Care and Use Commit-
tee.
Anesthesia
Animals, routinely four at a time, were anesthetized by
induction with 5% isoflurane (Piramal Healthcare, Mumbai,
India), which then was reduced to 2% for the period of IOP
exposure, using 100% O2 as the carrier gas. Isoflurane was
administered with a portable anesthesia machine (PAM) and
OHIO Isoflurane vaporizer using a Multiplex Delivery System
with 4 flowmeters and inline humidifiers. Animals were placed
in custom-built holders that stabilized the head, allowing
access to the eyes, incorporating a cone covering the external
nares, leading to anesthesia (Fig. 1A). Waste anesthesia gas was
actively collected with a Hallowell WAG interface valve
connected to house vacuum for removal of excess gas and
CO2. The portable anesthesia machine and accessories were
sourced from Patterson Scientific (Bend, OR, USA). Anesthetic
delivery and waste gas removal were set up in parallel for all
four animals, coming from or leading to a common unit.
CEI Exposure Paradigm
After topical 0.5% proparacaine application (Alcon Laborato-
ries, Inc., Fort Worth, TX, USA), a sterile disposable 31-gauge
needle, attached to Silastic tubing, was inserted obliquely (to
produce a self-sealing wound) through the cornea into the
anterior chamber. (Figs. 1A, 1B) To minimize lens and iris
damage, the needle was shortened to 1 cm and resharpened to
a 258 tri-bevel. The plastic hub was trimmed and connected to
Silastic tubing (Catalog #508-004; inner diameter/outer diam-
eter [ID/OD]¼0.7/1.65 mm; Dow Corning, Corning, NY, USA).
Two elastic bands (Fig. 1A, arrows) stabilized the needle and
also allowed accurate adjustment of the needle position.
Each Silastic tube was connected to larger tubing leading to
a 4-way manifold connected to a single reservoir that could be
raised or lowered to adjust inflow pressure, monitored by an
in-line pressure transducer. The entire system was filled with
BSS Plus (Alcon Laboratories, Inc.). Success at producing the
desired IOP was confirmed in separate experiments using a
transducer connected to a second anterior chamber cannula
(23 gauge) to directly measure IOP (Fig. 1C).
All animals were wrapped in circulating warm water
heating pads (388C) and hydrated every 30 minutes with
subcutaneous injection of 0.5 ml warm normal saline. Normal
saline and topical 0.5% proparacaine were applied alternatively
to both eyes every 15 minutes, and IOP was checked
independently every 30 minutes with a TonoLab tonometer
(Icare Finland Oy, Espoo, Finland) to detect deviations from the
target pressure significant enough to warrant evaluating tube
patency or leaks. At the end of CEI exposure, the IOP was
reduced to normal and the needle carefully removed.
FIGURE 1. Controlled elevation of IOP. (A) Custom-made head holder, anchoring the nose in the respiratory cone, with isoflurane delivery (green
tube) and an active exhaust for waste gas and CO2 (red and white fitting). Balanced saline solution (BSS) tubing is anchored to the holder by two
Silastic bands (arrows) that stabilize the needle, yet still allow delicate adjustment of the needle position in the eye. (B) Balanced salt solution PLUS
delivered through the cornea using a modified, 31-gauge needle shortened to 1 cm with a modified bevel, the hub of which is fitted to flexible
Silastic tubing (single arrow). Fixation of the animal’s head and the tubing to the same holder minimizes chance of the needle becoming dislodged.
(C) Intraocular pressure measured via a second anterior chamber needle (23-gauge) closely follows the intended pressure, delivered through a 31-
gauge needle, when IOP is raised from 20 to 60 mm Hg, confirming that pressure measured in the 31-gauge needle line accurately reflects actual
IOP.
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Erythromycin antibiotic ointment (0.5%) was applied to the
experimental eye and the animals were kept warm and
hydrated throughout recovery. All animals were killed under
deep isoflurane anesthesia at different times following CEI
exposure, depending on the specific experiment.
Because the extent and duration of IOP elevation can be
controlled in this model, we have chosen to identify different
combinations of these parameters by stating ‘‘CEI’’ followed by
the IOP level and hours of exposure, so that elevation of IOP to
60 mm Hg for 8 hours is ‘‘CEI 60-8’’ and 20 mm Hg for 8 hours
is ‘‘CEI 20-8’’.
Physiologic Monitoring
Physiologic monitoring was performed using a rat foot sensor
connected to a MouseOxPlus Oximeter (STARR Life Sciences
Corporation, Oakmont, PA, USA) with temperature and
recording module, using an 8-channel multiplexer to allow
monitoring of multiple animals. With this, real-time monitoring
and recording of percent oxygen saturation of functional
arterial hemoglobin, heart rate, respiratory rate, and pulse and
respiratory distention could be performed, with rectal
temperature in 1 of every 4 animals.
For blood pressure monitoring, animals were anesthetized
with isoflurane, laid supine, and the tail artery cannulated with
Tygon S-54-HL tubing, leading to a research grade blood
pressure transducer (Harvard Apparatus, Holliston, MA, USA)
with analog voltage output. The output of the pressure
transducer was connected to a National Instruments Analog
Input Module, with the signal recorded by National Instru-
ments Signal Express Data Logging and Interactive Measure-
ment Software (National Instruments, Austin, TX, USA). Mean
blood pressure, with standard deviation, then was calculated
for each animal from a decimated log of the pressure recording.
In preliminary experiments, direct comparisons of tail artery
pressures to readings from a similarly cannulated femoral
artery produced identical readings between the 2 sites (data
not shown).
In one group of 6 animals, all physiologic parameters,
including blood pressure, were monitored continuously and
recorded (1 Hz) for an entire 8 hours of anesthesia.
Optic Nerve Injury Assessment
Development of axonal injury was initially determined at
several time points following CEI in myelinated optic nerve
segments (postfixed in 4% paraformaldehyde and 5% glutaral-
dehyde) obtained at the time of ONH harvest for gene
expression analysis (described below). Two additional groups
of animals, used only for axonal injury assessment, underwent
CEI exposure of 50 and 60 mm Hg, respectively, and were
perfusion-fixed with an initial bolus of 100 ml buffered 4%
paraformaldehyde followed by 1000 ml of buffered 5%
glutaraldehyde. Eyes were enucleated and immersed in 5%
buffered glutaraldehyde. All fixatives were used at 48C.
Axonal injury was assessed in myelinated optic nerve cross-
sections qualitatively by grading the extent of axonal injury,
and quantitatively by counting degenerating axons. Fixed
nerve segments 1 to 2 mm from the globe were embedded in
plastic, sectioned, and stained with toluidine blue. For
qualitative injury grading, masked slides of the entire optic
nerve cross-section were assessed by light microscopy for
degenerating axons by at least four observers, using a grading
scale of nerve injury ranging from 1 (normal) to 5 (total
degeneration).26
For degenerating axon counts, nerve cross-sections that
together covered the entire nerve cross-section were digitally
photographed under oil immersion (3100). Deidentified
images were evaluated separately by three observers who
marked degenerating axons (identified by condensed axo-
plasm, presence of myelin remnants, or swollen, empty-
appearing axons) using Photoshop (Adobe Systems, San Jose,
CA, USA). The files then were unmasked and layered in
Photoshop and combined to create a montage of each optic
nerve cross-section. Axons identified as degenerating by at
least two observers were tallied for each nerve. Mean numbers
of degenerating axons for each group with SEM were
calculated and compared to counts for control eyes.
For statistical comparisons, the mean grade (or mean
number of degenerating axons, if less than grade 2) for each
group was calculated.
Electroretinography (ERG)
For ERG, animals were dark adapted overnight (>12 hours)
and prepared for recordings under dim red illumination (k >
600 nm). Initial anesthesia was accomplished by intraperito-
neal injection of ketamine (37.5 mg/kg; JHP Pharmaceuticals,
Rochester, MI, USA), xylazine (7.5 mg/kg; RXV, Greeley, CO,
USA), and acepromazine maleate (1.5 mg/kg; VET ONE, Boise,
ID, USA) with a supplemental dose of ketamine (15 mg/kg)
given after 1 hour. Pupil dilation and topical corneal anesthesia
were achieved using 0.5% tropicamide and 0.5% proparacaine
respectively (Alcon Laboratories). Body temperature was
maintained using a USB rechargeable warmer placed beneath
the animal. Paired, custom-made silver chloride electrodes
were placed on both eyes, with the reference electrode
situated circumferentially around the corneoscleral limbus and
the active electrode located at the corneal apex, using 0.5%
carmellose (Allergan, Parsippany, NJ, USA) as a coupling agent.
A subdermal needle electrode (Technomed Europe, Maastricht,
Netherlands) at the tail base served as the ground. Animals
were dark adapted for a further 10 minutes following electrode
placement before commencing the recording protocol.
Bilateral simultaneous ERGs were recorded using the UTAS
Visual Electrodiagnostic Testing System with brief, white light
stimuli delivered through a Bigshot Ganzfeld integrating sphere
(LKC Technologies, Gaithersburg, MD, USA). Scotopic thresh-
old responses were obtained for white flash (<5 ms duration)
stimuli, intensities ranging from 6.7 to 3.9 log cd.s.m2 in
0.2 log unit increments, by averaging 30 sweeps per intensity
with an interstimulus interval of 2 seconds. Scotopic ERGs
(from3.6 to 2.2 log cd.s.m2) were recorded by averaging 3
sweeps, with the interstimulus interval progressively increas-
ing from 10 to 120 seconds to allow complete recovery of the
B-wave. All recordings included a 10-ms prestimulus baseline
with data collected up to 500 ms after stimulus delivery.
Raw data were extracted using EMWin Software (LKC
Technologies) and exported into Excel (Microsoft, Redmond,
WA, USA) in digital voltage-time format for post hoc analysis.
Following source data verification, ERG response amplitudes
were measured at strict time criteria after the flash stimulus.
For responses to dimmer stimuli, a fixed criterion of 120 ms
was chosen to correspond to the peak of the scotopic
threshold response (pSTR). For scotopic responses to brighter
flash stimuli, fixed criterion times of 70 and 6.5 ms were used
to measure the amplitudes of the B-wave and A-wave,
respectively.
Eight animals had bilateral ERG recordings at baseline
(mean of two separate recordings), followed by unilateral
exposure to 60 mm Hg for 8 hours (CEI 60-8). Electroretino-
graphs then were repeated 2 days and 2 weeks after CEI
exposure. Intensity response functions of ERG response
amplitudes for experimental eyes were plotted at baseline,
which was compared to similar plots at 2 days and 2 weeks
following CEI IOP exposure.
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Gene Expression Analysis
Animals used for gene expression analysis were decapitated
under deep isoflurane anesthesia. Globes with attached,
myelinated optic nerves were quickly removed and placed in
ice cold PBS, and tissues were kept ice cold for the following
steps. After removing the optic nerve segment for injury
analysis, the globe was opened, and the anterior chamber, lens,
and retina removed. The nerve and ONH were removed using a
trephine and separated from any attached sclera. The nerve
head was placed in a custom matrix, trimmed to 0.4 mm length
to include the unmyelinated and transition regions, placed in a
microfuge tube and immediately frozen by plunging the tube
into dry ice pellets and then transferred to a808C freezer for
storage before RNA extraction.
Total RNA was purified from ONHs using the PicoPure RNA
Isolation Kit, according to the manufacturer’s instructions,
which includes DNAase treatment (Molecular Devices, Sunny-
vale, CA, USA). RNA was quantitated using the Quant-iT
RiboGreen assay (Invitrogen, Carlsbad, CA, USA). Relative
quantification by quantitative real-time reverse transcription
PCR (qPCR) was performed as described previously.25 Briefly,
30 ng of total ONH mRNA from each sample, as well as from a
pooled ONH RNA standard curve, was reverse transcribed and
amplified by PCR, using glyceraldehyde phosphate dehydroge-
nase (GAPDH) for normalization. Product identities were
confirmed by sequencing. Primers were designed using Clone
Manager (Sci-ed Software, State Line, PA, USA) using sequences
for rat mRNAs available in the NIH National Center for
Biotechnology Information databases. Quantitative real-time
reverse transcription PCR was performed on messages
obtained from ONH, providing enough material to test
approximately 15 messages per ONH.
Effects of CEI on gene expression were determined in two
experiments. In the first (CEI message experiment 1), 32
animals underwent CEI 60-8 and were killed either immedi-
ately (Time 0, without recovery from anesthesia) or at 12
hours, 3 days or 10 days after exposure (n ‡ 8 per time point)
and ONH gene expression compared to fellow eye controls at
each time point. Messages explored encompassed interleukin
6-type cytokine signaling pathways, cell proliferation, specific
cell markers, and extracellular matrix modifiers shown to be
significantly regulated in our chronic model.24,25 Controlled
elevation of IOP message experiment 2 was designed to
determine the effects of IOP, anesthesia, and anterior chamber
cannulation on ONH gene expression. A total of 16 animals
underwent CEI 60-8 and another 16 were exposed to 20 mm
Hg for 8 hours (CEI 20-8). Half of each group was killed either
immediately (Time 0) or 3 days after CEI exposure and
compared to a group of na¨ıve animals (anesthesia only before
sacrifice and no anterior chamber cannulation). Messages
evaluated were similar, but not identical, to those used in CEI
message experiment 1. Messages selected for evaluation,
including official and alternative gene names and official gene
acronyms, are listed in Table 1. Primers used are listed in
Supplementary Table S1.
Statistical Analysis
Group means (6 SD for physiologic parameters and TonoLab
IOP measurements; 6 SEM for nerve injury) were calculated
and comparisons were performed by t-test or ANOVA using
Graphpad Prism software (La Jolla, CA, USA). For ERG analysis,
statistical comparison for each of the three respective
responses was performed with a 2-way ANOVA with repeated
measures using Graphpad Prism software, with a null
hypothesis that no differences exist between the intensity-
response relationships recorded at baseline and those recorded
after IOP elevation. This analysis aimed to compare the
intensity-response relationships as a whole, rather than to test
differences at individual intensities, which are otherwise
generally correlated within each eye. For gene expression
analysis, the significance of differences between groups for
each studied message was determined by 1- or 2-way ANOVA
with Dunnett’s post test (or the Kurskal-Wallis test with Dunn’s
post test if Bartlett’s test for equal variances on the data
without or with log2 transformation indicated a significant
difference between the variances).
RESULTS
Animal Physiology Under Isoflurane Anesthesia
To determine the stability of physiologic parameters over a
typical CEI exposure, 6 animals were continuously monitored
for 8 hours under 2% isoflurane and the conditions described
in Methods. Mean systemic blood pressure for this group was
99 6 5 (SD) mm Hg while mean oxygen saturation, heart rate,
and respiratory rate were 99.2 6 0.2%, 338 6 11 beats per
minute, and 56 6 12 breaths per minute, respectively. Figure 2
shows a continuous tracing of these parameters in one animal,
demonstrating stability over the entire 8 hours. Table 2
presents two values for each parameter, each representing a
mean of all 6 animals, over two 15-minute periods, one
beginning 30 minutes after the onset of anesthesia and the
other ending 30 minutes before the end of anesthesia. There
were no significant differences between the beginning and
ending means for any of these parameters.
Overall, in 34 animals under anesthesia, isolated measure-
ments of systemic blood pressure ranged from 89 to 121 mm
Hg, with a mean of 99 6 6 (SD) mm Hg. In 18 animals
undergoing CEI, mean oxygen saturation, heart rate, and
respirations over the entire 8 hours were determined for each
animal and these then were used to calculate a group mean for
each parameter. These resulting overall means were 99.1 6
0.3% (range, 99–100%), 294 6 25 beats per minute (range,
254–343), and 48 6 10 breaths per minute (range, 36–76),
respectively.
TABLE 1. Messages Evaluated: Official Gene Names and Acronyms
Official Gene Name (Alternative Name)
Gene
Acronym
Allograft inflammatory factor 1 (Iba1) Aif1
Aquaporin 4 Aqp4
Cd68 molecule Cd68
Fibulin 2 Fbln2
Growth associated protein 43 Gap43
Glyceraldehyde phosphate dehydrogenase Gapdh
Glial fibrillary acidic protein Gfap
Gap junction protein alpha 1 (Connexin 43,Cx43) Gja1
Interleukin 6 Il6
Integrin subunit alpha V Itgav
Leukemia inhibitory factor Lif
Leukemia inhibitory factor receptor Lifr
Neurofilament, light polypeptide Nefl
Purinergic receptor P2Y12 P2ry12
Periostin (Osf2) Postn
Protein regulator of cytokinesis 1 Prc1
Rho associated coiled-coil containing protein kinase 2 Rock2
Suppressor of cytokine signaling 3 Socs3
Transforming growth factor beta 2 Tgfb2
Tenascin c (Hxb) Tnc
Topoisomerase (DNA) II alpha Top2a
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TonoLab IOP
In 45 eyes exposed to CEI 60-8, mean TonoLab readings for the
experimental eyes was 57 6 3 mm Hg (mean 6 SD), while that
of uncannulated, fellow eyes was 9.0 6 1 mm Hg. This was
confirmed by observations from CEI message experiment 2,
shown in Table 3. This Table summarizes IOPs in 32 additional
animals, 16 of whom underwent CEI 60-8 while the other 16
were exposed to CEI 20-8. TonoLab readings (mean 6 SD)
confirmed that IOP targets were achieved for both experimen-
tal eye groups (CEI 60-8¼ 57 6 2 mm Hg and CEI 20-8¼ 22 6
2 mm Hg). Mean TonoLab readings for all control fellow eyes in
this experiment (n¼ 32), under anesthesia, was 8 6 1 mm Hg.
All fellow eye pressures were well below that of previously
reported awake TonoLab IOP readings for normal eyes,37
which is most likely due to the pressure-lowering effects of
isoflurane anesthesia.38
Axonal Injury
Postfixed optic nerves revealed that optic nerve injury grade
was not significantly increased until 10 days following CEI
exposure (Fig. 3A) In 8 additional animals, perfusion-fixed for
assessing axonal degeneration, the injury grade 10 days after
CEI was 2.02 6 0.26 (SEM) versus 1.03 6 0.01 in fellow
controls (P < 0.002). This group demonstrated a mean (6
SEM) degenerating axon count of 321 6 107 per nerve
compared to 16 6 4 for fellows (P < 0.002; Figs. 3B, 3C). In
another group of 8 animals, exposed to 50 mm Hg for 8 hours
(CEI 50-8), mean degenerating axons per nerve was 42 6 11,
also significantly greater than that of fellow controls (P <
0.03). From these groups, along with additional CEI 60-8
animals, a total of 23 nerves with early injury was found in
which the ophthalmic artery was present, which lies inferior to
the optic nerve and provides a landmark for orientation.39 Of
these, 19 (83%) demonstrated a focal injury located in the
superior region of the optic nerve (Figs. 3D, 3E).
Electroretinography
Intensity response curves for pSTR, B-wave, and A-wave
amplitudes at 2 and 14 days following IOP exposure compared
to baseline levels are shown in Figure 4. Significant, transient
reductions in pSTR (51.9 6 12.4%; P < 0.0001), B-wave (19.5
6 9.8%; P < 0.0001), and A-wave (67.2 6 4.8%; P < 0.0001)
responses were observed 2 days following the CEI exposure.
Two weeks after IOP exposure, no lasting impact upon the B-
wave or A-wave responses (representing bipolar cell and
photoreceptor function, respectively) was observed, with
amplitudes comparable to baseline levels (P > 0.05). However,
a small, but significant, residual deficit in the pSTR response
(representing RGC function) was evident at this time point (P
¼ 0.005).
ONH Gene Expression Changes in Response to CEI
60-8 (CEI Message Experiment 1)
We initially asked if selected gene expression responses
previously determined to occur in studies of our chronic
glaucoma model also would be observed following CEI24,25
(See Table 1 for full gene names and acronyms). Because we
knew the onset and duration of CEI exposure, we also were
able to determine, by euthanizing animals at specific time
points, the relative timing of these different responses, as well
as their recovery patterns. These results are summarized
graphically in Figure 5. Specific values for all of these messages
at each time point are listed in Supplementary Table S2.
Immediately following CEI (Time 0, without any recovery
from anesthesia) the most profoundly regulated messages were
consistent with interleukin 6-type cytokine signaling (Fig. 5A).
Cytokines Il6 and Lif demonstrated an immediate, significant
elevation. Whereas Il6 normalized by 3 days, Lif remained
significantly elevated, even at 10 days, albeit substantially
reduced from its earlier peak. Socs3, a negative feedback
regulator of Jak-Stat signaling, also was significantly elevated at
Time 0. This normalized by 10 days, although not as rapidly as
Il6. Lifr expression, the protein of which can be reduced in
astrocytes by Lif,40 exhibited a significant reduction, apparent
FIGURE 2. Continuous tracing of heart rate, percent blood oxygen
saturation, systemic blood pressure, and respiratory rate over 8 hours
in one animal under 2% isoflurane anesthesia. Note stable values for all
parameters over the entire observation period. Error bars: standard
deviation.
TABLE 2. Physiologic Parameters for 6 Animals Over an 8-Hour Period,
Comparing Means of a 15-Minute Period 30 Minutes After the
Beginning of Anesthesia to a Similar Period 30 Minutes Before the End
Physiologic
Parameter
Beginning
6 SD
Ending
6 SD P Value*
Blood pressure, mm Hg 96.7 6 3.7 98.1 6 3.6 0.26
% Blood O2 saturation 99.3 6 0.2 99.3 6 0.1 0.53
Heart rate, bpm 346 6 13 323 6 30 0.13
Respiratory rate, bpm 53 6 16.3 50 6 11.3 0.28
* Differences between the beginning and ending values were not
statistically significant (paired t-test).
TABLE 3. TonoLab IOP Readings for Animals Exposed for 8 Hours to
Either 60 mm Hg (CEI 60-8) or 20 mm Hg (CEI 20-8) Compared to
Fellow, Uncannulated Eyes
Cei Condition 60-8 20-8
All Fellow
Eyes
Mean IOP 6 SD, mm Hg* 57.2 6 2.2 22.1 6 2.3 8.3 6 1.1
n 16 16 32
* A total of 16 measurements were made per animal.
Responses to Controlled Elevation of IOP IOVS j December 2016 j Vol. 57 j No. 15 j 6704
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935913/ on 05/18/2017
at Time 0, with no evidence of recovery over the entire follow-
up period.
Markers for cell proliferation, Top2a and Prc1, also
demonstrated significant increases in gene expression. How-
ever, this was delayed. After an initial, nonsignificant
depression, messages for both markers were significantly
elevated at 3 days and remained so at 10 days, with some
evidence of recovery. Tgfb2, hypothesized to promote fibrotic
changes in the glaucomatous optic nerve head,41–43 was
significantly reduced by 12 hours after exposure and remained
so through the remainder of the 10-day postexposure
observation period. This was consistent with our chronic
model observations,24 Postn, Tnc, and Fbn2, representing the
matricellular class of extracellular matrix proteins, were all
significantly elevated at 12 hours and 3 days, with signs of
normalization by 10 days.
Figure 5B illustrates message responses for cell-type
markers. The axonally-contained mRNA Nefl polypeptide and
Gap43 were initially increased. However, both demonstrated a
significant decrease 3 days after IOP exposure which, by 10
days, was further reduced to as little as 16% and 27% of control
values, respectively.
Astrocyte markers Gfap, Gja1 (or Connexin 43), and Aqp4
all failed to demonstrate significant elevations. Rather, Gja1
was significantly reduced immediately after IOP exposure, and
messages for all three were moderately, but significantly
FIGURE 3. Optic nerve injury following CEI. (A) Assessment of axonal injury grade in postfixed optic nerve cross-sections shows that significant
injury does not appear until 10 days following CEI exposure. Two columns on far right demonstrate injury grade in perfusion-fixed experimental
and control eyes 10 days after CEI 60-8 (n¼ a minimum of 8 for all groups). (B) Degenerating axon identified by 3 observers (arrows) under oil
immersion for degenerating axon counts. (C) Degenerating axon counts are significantly higher in CEI 60-8 and CEI 50-8 nerves than in fellow
control eyes. (D) Cross-section of CEI 60-8 nerve (injury grade 2.14), showing superior location of injury (red outline) relative to inferiorly located
ophthalmic artery (red asterisk). (E) Detail of degenerating axons in boxed area from (D). Asterisks in (A) and (C) indicate a statistically significant
difference from control values (P < 0.05).
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reduced 12 hours after IOP elevation. All returned to normal by
day 3.
The microglial marker P2ry12, abundant in brain microg-
lia,44 was significantly decreased initially but normalized by
day 3. Such decreases may be associated with microglial pro-
cess retraction to a more ameboid (activated) morphology.45
Aif1 (or Iba1) demonstrated a small, but significant increase at
day 3.
ONH Message Changes Are Not Associated With
Cannulation or Prolonged Anesthesia (CEI
Message Experiment 2)
Here, animals were exposed unilaterally to either CEI 60-8 or
CEI 20-8 and killed at either Time 0 or 3 days after IOP
exposure. Message responses for all groups of ONHs were
compared to a separate group of ONH from na¨ıve eyes that had
undergone neither prolonged anesthesia nor cannulation.
FIGURE 4. Intensity-response functions of eyes 2 days (left panel) and 14 days (right panel) following CEI 60-8 exposure compared to baseline.
Electroretinogram amplitude (group mean 6 SEM) versus stimulus intensity for eyes following CEI (filled symbols, n ¼ 8) and baseline (open
symbols, n ¼ 8). (A) Positive scotopic threshold response (pSTR) amplitude measured at 120 ms after the stimulus flash. (B) Scotopic B-wave
amplitude measured at 70 ms after the stimulus flash. (C) Scotopic A-wave amplitude measured at 6.5 ms after the stimulus flash.
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Significant differences were seen only in ONHs undergoing CEI
60-8 and these appear in Table 4. Neither CEI 20-8 nor fellow
control ONHs of either experimental group (anesthesia only)
demonstrated significant message level responses compared to
na¨ıve tissues. All responses, compared to na¨ıve ONHs, are
listed in Supplementary Table S3.
Among messages not evaluated in CEI message experiment
1, Rock2, important for modulating actin cytoskeleton
organization and cell adhesion, was mildly, yet significantly
elevated 3 days following CEI-60. Cell markers for astrocytes
(Gfap), microglia (Cd68), and the vascular-associated Itgav all
failed to show significant changes in any condition and at any
time point.
DISCUSSION
Working with an established model of chronic IOP elevation,
we have reported previously that mild or early optic nerve
damage is associated with prominent changes in ONH gene
expression for processes involved in interleukin 6-type
cytokine signaling and cell proliferation, as well as alterations
FIGURE 5. Initial observations on message responses, compared to control eyes, immediately after IOP exposure (0 hours), along with recovery
times of 12 hours, 3 days, and 10 days. (A) IL6-type and JAK signaling demonstrate robust, early response while significant gene expression changes
associated with cell proliferation are delayed to day 3. Message levels for the cytokine Tgfb2 are downregulated during recovery. Matricellular
proteins Tnc, Postn, and Fbln2, show patterns of upregulation that peak between 12 hours and 3 days after CEI exposure. (B) Cell-type markers
show various response patterns. Axonal-associated mRNAs are initially elevated at 0 time, and dramatically fall during recovery. Astrocyte markers
are transiently depressed at 3 days, but then recover. Microglial P2ry12 demonstrates a transient but significant downregulation, followed by
normalization. Aif1 levels are significantly increased at 3 days recovery. Note that the y-axis is a log2 scale that is different in magnitude between the
two charts. *Indicates a statistically significant difference from control values. n is equal to or greater than 8 per group. For each message, control
eye variability is indicated by the error bars on the left.
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in the extracellular matrix and several cell-type markers.24
However, while IOP can be measured at frequent intervals, the
exact level and duration of pressure elevation still cannot be
determined without continuous telemetric IOP monitoring. As
a result, the precise timing and relationships of these responses
to each other, and to the injury itself, is unknown; some could
be initial, injury-initiating responses, while others may be
secondary to axonal injury, or protective reactions. To address
this problem, we decided to determine if axonal injury and
ONH gene expression changes known to occur in chronic
glaucoma models24,25 also would be observed using controlled
elevation of IOP applied over a time period suitable for
laboratory study.
Initial experiments using IOPs of 40 mm Hg and 4-hour
exposures led to moderate gene expression changes but
inconsistent evidence of optic nerve injury (data not shown).
We ultimately decided to use an 8-hour pressure exposure, as
this offered a better opportunity to produce focal axonal injury
and significant ONH responses. Abbott et al.46 have reported
that an 8-hour exposure to 50 mm Hg in rats produced initial
nerve fiber layer thickening as determined by spectral domain
optical coherence tomography, but no significant long-term
thinning, RGC loss or lasting deficits in axonal transport.46 By
assessing axonal injury,26,47 we found in our present CEI model
that 50 mm Hg produced axonal injury that could be detected
only by quantifying degenerating axons (Fig. 3C). By compar-
ison, 60 mm Hg produced optic nerve injury identifiable by
qualitative and quantitative methods. This pressure is equal to
peak IOPs reported in chronic models using nonhuman
primates27,28,48 and rodents,14,49–52 yet still is well below the
110 to 120 mm Hg generally used for studying ischemia/
reperfusion.53,54 Although degenerating axon counts, per-
formed by light microscopy are likely an underestimate of
total injury, the extent of axon loss in this model is mild and
likely less than inter-eye variability in axon count.55
An essential feature of the CEI model is the high degree of
control it provides over the extent and duration of IOP
exposure. As shown in Figure 1C, actual IOP closely mirrors
the intended pressure. The extensive TonoLab data in Table 2,
consisting of 16 readings per animal over the entire 8 hours,
further supported this, and demonstrated that pressures can be
efficiently and uniformly delivered to as many as 4 animals at a
time.
Because the CEI model requires IOP elevation for several
hours, general anesthesia is essential. We chose to use
inhalational isoflurane as it produces excellent general
anesthesia with minimal animal movement which, coupled
with flexible tubing and specific features of the head holder,
successfully minimized intraocular trauma. Because this agent
can lower systemic blood pressure, we carefully monitored this
parameter and found that, using the conditions described here,
including active removal of waste gas and CO2,
56 mean blood
pressure averaged 100 mm Hg. This is comparable to that
reported in rats using isoflurane for shorter periods of time, as
well as other anesthetics.57–59 Importantly, through continuous
monitoring, we confirmed that blood pressure, as well as heart
rate, oxygen saturation, and respiratory rate, all remained
stable over the entire 8 hours.
Given this level of systemic blood pressure, an IOP of 60 mm
Hg provides a perfusion pressure of 40 mm Hg, which is
sufficient to maintain retinal and ONH perfusion to at least 80%
of baseline, as determined previously using optical coherence
tomography angiography56,60,61 and other methods.62 Above 60
mm Hg, perfusion decreases rapidly. Bui et al.35 showed that an
IOP of 60 mm Hg or less for 105 minutes allowed full recovery
of all components of the ERG, whereas 70 mm Hg or higher
prevented full recovery of the ERG and produced cell loss in the
RGC layer. They concluded that there exists a ‘‘threshold’’
between 60 and 70 mm Hg, above which permanent functional
retinal loss will occur, most likely due to ischemia.35,63
Our electrophysiologic findings confirmed these results.
They also showed that extending exposure at 60 mm Hg to 8
hours, well beyond the 105 minutes reported by Bui et al.,35
does not have a lasting effect upon major components of either
the outer or inner retinal function, represented by the A-wave
and B-wave intensity plots, respectively. Both were unaffected
2 weeks following this single insult, confirming the absence of
long-term ischemic sequelae.
However, our 2-week data did reveal a small, but statistically
significant residual reduction in the pSTR. This component of
the ERG has been shown to correlate well with damage to RGC
soma in the inner retina and axons within the optic nerve64,65
and this finding is consistent with our histologic observation of
mild axonal injury within the optic nerve (Fig. 3). Thus, it
appears that extending exposure to 8 hours elicits a selective
effect on the pSTR. Since this component of the ERG has been
associated with injury from lower levels of IOP elevation in our
chronic model,49 this supports the applicability of ONH
findings in the CEI model to chronic animal glaucoma models,
as well as to human glaucoma.
It is important that optic nerve injury in this model is
primarily focal and located in the superior region of the optic
nerve. This is consistent with superior peripapillary retinal
thinning observed by Fortune et al.66 during acute IOP
elevation in rats and with observations in chronic models by
ourselves5 and several other investigators. Dai,67 using intra-
camerally injected magnetic microspheres to elevate IOP,
described ultrastructural evidence of axonal degeneration in
the superior ONH and proposed a mechanism for this based on
changes in astrocyte morphology in this region. Others, using
laser-induced IOP elevation, reported preferential loss of nerve
fiber layer axons and RGCs in the superior retina in rats29,68,69
TABLE 4. Significant Gene Expression Responses Following 8 Hours’ Exposure to 60 mm Hg (CEI 60-8) Versus 20 mm Hg (CEI 20-8), to Determine
the Effect of Anesthesia, Anterior Chamber Cannulation and Elevated IOP
Message
CEI 60-8 Recovery Time CEI 20-8 Recovery Time
0 Time 3 Days 0 Time 3 Days
Il6 11,064% 6 4391%* 123% 6 29% 200% 6 58% 114% 6 66%
Lif 8520% 6 3200%* 793% 6 335% 124% 6 20% 116% 6 20%
Nefl 143% 6 27% 54% 6 7%* 184% 6 41% 89% 6 24%
Rock2 133% 6 11% 137% 6 11%* 110% 6 13% 112% 6 10%
Tgfb2 79% 6 11% 69% 6 6%* 81% 6 4% 110% 6 7%
Top2a 79% 6 14% 279% 6 86%* 90% 6 11% 106% 6 16%
* Indicates significant change compared to Na¨ıve ONH. Only CEI 60-8 ONH demonstrated significant changes in gene expression compared to
na¨ıve ONH. Five other messages (Cd68, Gfap, Intga, Postn, and Tnc) were not significantly changed in expression in this study. Complete results,
including message values in anesthetized fellow eyes are available in Supplementary Table S3. n ‡ 7 for all groups.
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and mice.70 Recently, Pazos et al.71 have noted that axon
bundles in the superior region of the rat ONH are closely
associated with Bruch’s membrane, whereas inferior bundles
are separated from Bruch’s by the central retinal vein and
artery.71 Since this connection may allow more direct
transmission of mechanical stress from elevated IOP to the
superior neural tissue, this could provide an anatomic
explanation for regional susceptibility in these models. Further
work with the CEI model will help reveal the cellular basis for
this phenomenon and provide new insights into axon injury
mechanisms associated with elevated IOP.
While future work will carefully assess genome-wide
expression in the optic nerve head tissue in this model, the
qRTPCR data from CEI message experiments 1 and 2 do
demonstrate that the CEI approach can produce many of the
gene expression changes that already have been observed in
the hypertonic saline chronic model, summarized in Supple-
mentary Table S4.24 All of these occurred only in eyes with
elevated IOP, confirming that these responses are associated
with elevated IOP and not the result of either anesthesia or
anterior chamber cannulation. It is important to note that this
association is not proof that these responses all contribute to
chronic injury. While they might be integral to the fundamental
molecular mechanism that leads to axonal injury and
glaucomatous vision loss, they also could be secondary to
axonal loss regardless of the primary insult, or they could be
simply ONH cell responses to elevated IOP. Fortunately, the
CEI model, with its tight control over IOP exposure, offers
opportunities to differentiate among these possibilities.
In early glaucoma damage,24 we noted that interleukin 6-type
cytokine signaling processes were highly upregulated. These
include Il6 and Lif, which activate via the Jak-Stat pathway,
leading to upregulation of the feedback inhibitor, Socs3, which
also was elevated. This signaling pathway triggers cellular
responses, including inflammatory, immune, and neuroprotec-
tive responses, as well as cell proliferation.72 Because of the
ability of this pathway to stimulate glial cell differentiation and
proliferation,24,73–76 we speculated then that interleukin 6-type
cytokine alterations may be contributing to the proliferative
responses we observed with early injury, demonstrated by
upregulation of cell cycle genes Top2a and Prc1 in the ONH.
In the CEI model, Il6, Lif, and Socs3 were significantly
upregulated immediately at Time 0 (Fig. 5A). By studying
changes at progressively longer times following IOP exposure,
we also were able to show that these changes preceded
activation of cell proliferation, which was not evident until day
3. This chronology, something that we could not demonstrate
with our chronic model, is consistent with the possibility that
proliferation responses may, indeed, be driven, in part, by
cytokine signaling.
In our assessment of cell markers, (Fig. 5B) we noted an
initial increase in axonally-associated Nefl and Gap43, which
may represent obstruction of axonal transport during IOP
elevation. Interestingly, this was followed by a significant
reduction that continued to decrease over 10 days to levels as
little as 16% and 27% of baseline, respectively. This, too, is
similar to what we observed previously in our chronic
model.24 While this could suggest profound axonal damage
and potentially ongoing loss of RGCs, this seems unlikely as we
have noted little evidence of increased injury at 14 and 21 days
following CEI in subsequent experiments (data not shown).
Regardless, these observations do suggest that IOP-induced
abnormalities of axonal transport may be more complicated
than currently appreciated and warrant further investigation in
future studies using this model, including recovery times
beyond the 10 days shown here.
Although developed to improve our understanding of early
genomic responses of the ONH to elevated IOP, the CEI model
offers opportunities to study other aspects of optic nerve as
well as retinal damage. These include the role of precondi-
tioning and prosurvival pathways in response to IOP, and the
highly clinically relevant question of whether a repeat IOP
exposure has a protective effect or actually leads to increased
vulnerability of the nerve. The persistent depression of Lifr,
despite recovery of its negative regulators Lif and Socs3,40,77
present the possibility that complex delayed or altered
recovery of certain responses may have an important role in
the effect of repeat exposure on susceptibility. Additional uses
could be to compare cellular mechanisms of axonal injury from
IOP to those that result from other types of insults, including
ischemia, direct axonal injury (experimental axotomy), and the
influence of age on all of these processes. It should, however,
be remembered that isoflurane does have neuroprotective
properties.78–80 While this does not appear to fundamentally
affect the IOP-induced gene expression changes within the
ONH, careful controls, similar to those used here, still must be
employed, particularly if this model were to be used for
experimental neuroprotection studies.
In summary, we have shown that a single, 8-hour CEI
exposure reproduces significant, but mild optic nerve damage
and gene expression changes within the ONH previously found
to occur in chronic IOP elevation models. These responses are
independent of anesthesia and anterior chamber cannulation.
The stability of the IOP and its fidelity to the intended pressure,
along with the stability of animal physiology over the entire
experiment all support this as a reliable approach for studying
ONH cellular processes involved in pressure-induced axonal
injury.
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